FDA Advisory Committee Unanimously Supports beti-cel Gene Therapy for People with beta-thalassemia Who Require Regular Red Blood Cell Transfusions Read more about FDA Advisory Committee Unanimously Supports beti-cel Gene Therapy for People with beta-thalassemia Who Require Regular Red Blood Cell Transfusions
FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy Read more about FDA Advisory Committee Unanimously Endorses eli-cel Gene Therapy for Cerebral Adrenoleukodystrophy
bluebird bio stock trading halted today June 9th and tomorrow June 10th Read more about bluebird bio stock trading halted today June 9th and tomorrow June 10th
bluebird bio Announces Posting of Briefing Documents for Upcoming FDA Advisory Committee Meeting Read more about bluebird bio Announces Posting of Briefing Documents for Upcoming FDA Advisory Committee Meeting
bluebird bio at Goldman Sachs 43rd Annual Global Healthcare Conference Read more about bluebird bio at Goldman Sachs 43rd Annual Global Healthcare Conference
bluebird bio at 2022 RBC Capital Markets Global Healthcare Conference Read more about bluebird bio at 2022 RBC Capital Markets Global Healthcare Conference
bluebird bio at BofA Securities 2022 Health Care Conference Read more about bluebird bio at BofA Securities 2022 Health Care Conference
bluebird bio Reports First Quarter 2022 Financial Results and Highlights Operational Progress Read more about bluebird bio Reports First Quarter 2022 Financial Results and Highlights Operational Progress
bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US Read more about bluebird bio Initiates Restructuring to Reduce Operating Expenses and Advance Near-term Opportunities to Bring Potentially Curative Gene Therapies to Patients in the US